Rated “exceptional” by the National Cancer Institute, Roswell Park is the only NCI-designated comprehensive cancer center in Upstate New York and a national leader in cancer research, treatment, screening and prevention. The organization is consistently recognized among the nation’s leading cancer centers and continues to advance molecular diagnostics, immunotherapies and cellular therapies that improve outcomes for patients with complex cancers. Additional distinctions include Magnet recognition for nursing excellence, Optum centers of excellence designations for adult and pediatric cancer care and stem cell transplantation, and accreditation through multiple American College of Surgeons/Commission on Cancer quality programs. Since its founding in 1898 as the first center dedicated to cancer research, Roswell Park has generated numerous landmark discoveries and innovations, including the PSA prostate cancer test, pioneering advances in cancer chemotherapy and SurVaxM, a novel immunotherapy currently in late-stage clinical development as a treatment for glioblastoma brain tumors. Home to New York State’s first and largest cell therapy hub, a portfolio of more than 400 active clinical trials and an award-winning community outreach and engagement program, Roswell Park serves as a national destination for complex cancer care and services.
